Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms, Castration-Resistant × apalutamide × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 33 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castrate-sensitive Prostate Cancer 1 Castration Levels of Testosterone 1 Adenocarcinoma 1

Interventions

Prednisone 6 enzalutamide 5 Docetaxel 4 Abiraterone Acetate 4 niraparib 2 darolutamide 2 abiraterone 2 olaparib 1 fludrocortisone acetate 1 cabazitaxel 1 Rosuvastatin Calcium 1 Pluvicto 1 Pioglitazone 1 Omeprazole 1 Nivolumab 1 Ipilimumab 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1 CTLA-4 Antigen 1 Artificial Intelligence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡